A small case series of patients who received one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine found that vaccination was not associated with worsening symptoms or quality of life in patients with persisting symptoms after acute COVID-19. These findings may help to assuage vaccine hesitancy in patients with persistent symptoms. A case report is published in Annals of Internal Medicine.